ICLR · ICON plc Ordinary Shares
View on chartInsiders & Stakes
| Ciaran Murray Director | ▼ Sell | Open Market | 20,452 Shares held | 8/11/2026 | View profile |
| Linda Grais Director | ▼ Sell | Open Market | 6,162 Shares held | 8/11/2026 | View profile |
| Nigel Bernard John Clerkin Chief Financial Officer | ▼ Sell | Open Market | 5,881 Shares held | 8/11/2026 | View profile |
| Barry Edward Balfe Chief Executive Officer | ▼ Sell | Open Market | 4,804 Shares held | 8/10/2026 | View profile |
| Ronan Martin Murphy Director | ▼ Sell | Open Market | 3,847 Shares held | 9/17/2026 | View profile |
| Eugene Pacelli McCague Director | ▼ Sell | Open Market | 3,811 Shares held | 9/17/2026 | View profile |
| Julie O'Neill Director | ▼ Sell | Open Market | 3,515 Shares held | 8/11/2026 | View profile |
| John Dr Climax Director | ▼ Sell | Open Market | 2,087 Shares held | 9/16/2026 | View profile |
| Anne Clem Whitaker Director | ▼ Sell | Open Market | 891 Shares held | 8/11/2026 | View profile |
Transaction History
| Eugene Pacelli McCague | ▲ Buy | Option Exercise | 3,255 | $409K | 9/17/2026 |
| Eugene Pacelli McCague | ▼ Sell | Open Market | 3,255 | $570K | 9/17/2026 |
| Ronan Martin Murphy | ▲ Buy | Option Exercise | 5,005 | $629K | 9/17/2026 |
| Ronan Martin Murphy | ▼ Sell | Open Market | 5,005 | $876K | 9/17/2026 |
| John Dr Climax | ▲ Buy | Option Exercise | 5,005 | $629K | 9/16/2026 |
| John Dr Climax | ▼ Sell | Open Market | 5,005 | $876K | 9/16/2026 |
| Nigel Bernard John Clerkin | ▼ Sell | Open Market | 237 | $39K | 8/11/2026 |
| Linda Grais | ▼ Sell | Open Market | 87 | $14K | 8/11/2026 |
| Nigel Bernard John Clerkin | ▼ Sell | Open Market | 1,591 | $262K | 8/11/2026 |
| Nigel Bernard John Clerkin | ▼ Sell | Open Market | 180 | $30K | 8/11/2026 |
| Eugene Pacelli McCague | ▼ Sell | Open Market | 590 | $97K | 8/11/2026 |
| Linda Grais | ▼ Sell | Open Market | 590 | $97K | 8/11/2026 |
| John Dr Climax | ▼ Sell | Open Market | 88 | $14K | 8/11/2026 |
| Linda Grais | ▼ Sell | Open Market | 97 | $16K | 8/11/2026 |
| Eugene Pacelli McCague | ▼ Sell | Open Market | 67 | $11K | 8/11/2026 |
| John Dr Climax | ▼ Sell | Open Market | 591 | $97K | 8/11/2026 |
| John Dr Climax | ▼ Sell | Open Market | 67 | $11K | 8/11/2026 |
| John Dr Climax | ▼ Sell | Open Market | 95 | $16K | 8/11/2026 |
| Nigel Bernard John Clerkin | ▼ Sell | Open Market | 259 | $42K | 8/11/2026 |
| Eugene Pacelli McCague | ▼ Sell | Open Market | 96 | $16K | 8/11/2026 |
| Linda Grais | ▼ Sell | Open Market | 67 | $11K | 8/11/2026 |
| Anne Clem Whitaker | ▼ Sell | Open Market | 88 | $14K | 8/11/2026 |
| Anne Clem Whitaker | ▼ Sell | Open Market | 96 | $16K | 8/11/2026 |
| Anne Clem Whitaker | ▼ Sell | Open Market | 590 | $97K | 8/11/2026 |
| Anne Clem Whitaker | ▼ Sell | Open Market | 67 | $11K | 8/11/2026 |
| Julie O'Neill | ▼ Sell | Open Market | 95 | $15K | 8/11/2026 |
| Julie O'Neill | ▼ Sell | Open Market | 105 | $17K | 8/11/2026 |
| Julie O'Neill | ▼ Sell | Open Market | 642 | $106K | 8/11/2026 |
| Julie O'Neill | ▼ Sell | Open Market | 73 | $12K | 8/11/2026 |
| Ciaran Murray | ▼ Sell | Open Market | 280 | $46K | 8/11/2026 |
| Ciaran Murray | ▼ Sell | Open Market | 305 | $50K | 8/11/2026 |
| Ciaran Murray | ▼ Sell | Open Market | 1,880 | $309K | 8/11/2026 |
| Ciaran Murray | ▼ Sell | Open Market | 212 | $35K | 8/11/2026 |
| Ronan Martin Murphy | ▼ Sell | Open Market | 88 | $14K | 8/11/2026 |
| Ronan Martin Murphy | ▼ Sell | Open Market | 96 | $16K | 8/11/2026 |
| Ronan Martin Murphy | ▼ Sell | Open Market | 590 | $97K | 8/11/2026 |
| Ronan Martin Murphy | ▼ Sell | Open Market | 67 | $11K | 8/11/2026 |
| Eugene Pacelli McCague | ▼ Sell | Open Market | 88 | $14K | 8/11/2026 |
| John Dr Climax | ▲ Buy | Option Exercise | 1,732 | — | 8/10/2026 |
| Nigel Bernard John Clerkin | ▲ Buy | Option Exercise | 918 | — | 8/10/2026 |
| Linda Grais | ▲ Buy | Option Exercise | 1,732 | — | 8/10/2026 |
| Nigel Bernard John Clerkin | ▲ Buy | Option Exercise | 3,375 | — | 8/10/2026 |
| Anne Clem Whitaker | ▲ Buy | Option Exercise | 1,732 | — | 8/10/2026 |
| Julie O'Neill | ▲ Buy | Option Exercise | 1,732 | — | 8/10/2026 |
| Ciaran Murray | ▲ Buy | Option Exercise | 2,677 | — | 8/10/2026 |
| Ronan Martin Murphy | ▲ Buy | Option Exercise | 1,732 | — | 8/10/2026 |
| Eugene Pacelli McCague | ▲ Buy | Option Exercise | 1,732 | — | 8/10/2026 |
| Barry Edward Balfe | ▼ Sell | Open Market | 304 | $50K | 8/10/2026 |
| Barry Edward Balfe | ▼ Sell | Open Market | 78 | $13K | 8/10/2026 |
| Barry Edward Balfe | ▲ Buy | Option Exercise | 728 | — | 8/7/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Icon plc (ICLR) gets new US trial boost and UBS price target update
Icon plc is highlighted by a U.S. Health and Human Services project aimed at speeding up clinical trials, which could improve the pace of its drug development. UBS has lifted its rating to neutral and set a $195 target, reflecting confidence in the company’s prospects. The stock sits near a key support level and shows a mild RSI, indicating moderate purchase pressure. These developments suggest increased attention from analysts and potential for short‑term volatility.
Icon plc (ICLR) gets new US trial boost and UBS price target update. Icon plc is highlighted by a U.S. Health and Human Services project aimed at speeding up clinical trials, which could improve the pace of its drug development. UBS has lifted its rating to neutral and set a $195 target, reflecting confidence in the company’s prospects. The stock sits near a key support level and shows a mild RSI, indicating moderate purchase pressure. These developments suggest increased attention from analysts and potential for short‑term volatility.